Ancestry $99 Health + Ancestry $199
23andMe kit 23andMe kit
Father's Day is June 18.

Father's Day is June 18. Save $20.

Save $20 / kit (limit 2)

Limit 2 kits. Offer ends June 18.

no membership fees
no monthly subscription

Two easy ways to discover you.

Choose what's right for you.

Ancestry Features

Ancestry
Service

learn more

$99

Health + Ancestry
Service

learn more

$199

Ancestry reports 4 reports including: Ancestry Composition, Haplogroups, Neanderthal Ancestry, Your DNA Family
DNA Relative Finder (opt in) Find and connect with relatives in the 23andMe database who share DNA with you.
Health Features See full list of reports
Genetic Health Risk reports* 4 reports including: Alpha-1 Antitrypsin Deficiency, Hereditary Thrombophilia, Late-Onset Alzheimer's Disease, Parkinson's Disease  
Carrier Status reports* 40+ reports including: Cystic Fibrosis, Sickle Cell Anemia, Hereditary Hearing Loss  
Wellness reports 5+ reports including: Deep Sleep, Lactose Intolerance, Genetic Weight  
Traits reports 15+ traits including: Male Bald Spot, Sweet vs. Salty, Unibrow  
Other Features
Raw Data Access your raw, uninterpreted genetic data file.** Must not be used for medical or diagnostic purposes.
Share, compare and discover more with friends and family Trace DNA through your close family and explore the genetic similarities and differences between you and family members. Ancestry
reports only
Health + Ancestry
reports
Add Genetic Health Risk*, Carrier Status*, Wellness and Traits reports Add later
for $125
Included!
You save $25.
Health + Ancestry discount: 10% off of each additional kit  
 

$99

add to cart

$199

add to cart
Ancestry Features

Health + Ancestry
Service

learn more

$199

Ancestry
Service

learn more

$99

Ancestry reports 4 reports including: Ancestry Composition, Haplogroups, Neanderthal Ancestry, Your DNA Family
DNA Relative Finder (opt in) Find and connect with relatives in the 23andMe database who share DNA with you.
Health Features See full list of reports
Carrier Status reports* 35+ reports including: Cystic Fibrosis, Sickle Cell Anemia, Hereditary Hearing Loss  
Wellness reports 5+ reports including: Deep Sleep, Lactose Intolerance, Saturated Fat and Weight  
Traits reports 15+ traits including: Male Bald Spot, Sweet vs. Salty, Unibrow  
Other Features
Raw Data Access your raw, uninterpreted genetic data file.** Must not be used for medical or diagnostic purposes.
Share, compare and discover more with friends and family Trace DNA through your close family and explore the genetic similarities and differences between you and family members. All
reports
Ancestry
reports only
Add Wellness, Traits and Carrier Status* reports Included!
You save $25.
Add later
for $125
Health + Ancestry discount: 10% off of each additional kit  
 

$199

add to cart

$99

add to cart
 

Ancestry
Service

learn more

$99

Health + Ancestry
Service

learn more

$199

Ancestry reports 4 reports including: Ancestry Composition, Haplogroups, Neanderthal Ancestry, Your DNA Family
DNA Relative Finder (opt in) Find and connect with relatives in the 23andMe database who share DNA with you.
Carrier Status reports* Example reports include: Cystic Fibrosis, Sickle Cell Anemia, Hereditary Hearing Loss  
Wellness reports Example reports include: Deep Sleep, Lactose Intolerance, Saturated Fat and Weight  
Traits reports Example reports include: Male Bald Spot, Sweet vs. Salty, Unibrow  
See full list of reports
 

$99

add to cart

$199

add to cart

*The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001) for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. The relevance of each report varies based on ethnicity. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person's overall risk of developing the disease. These reports are not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication or how much of a medication you should take. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future or anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For Gaucher Disease Type 1, we provide a single report that includes information on both carrier status and genetic health risk. The Late-onset Alzheimer's Disease genetic health risk report is indicated for reporting of the ε4 variant in the APOE gene and describes if a person has a variant associated with an increased risk of developing late-onset Alzheimer's disease. The ε4 variant included in this report is found and has been studied in many ethnicities. Detailed risk estimates have been studied the most in people of European descent. The Alpha-1 Antitrypsin (AAT) Deficiency genetic health risk report (i) is indicated for reporting of the PI*Z and PI*S variants in the SERPINA1 gene, (ii) describes if a person has variants associated with AAT deficiency and a higher risk for lung and liver disease, and (iii) is most relevant for people of European descent. The Parkinson's Disease genetic health risk report (i) is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene, (ii) describes if a person has variants associated with an increased risk of developing Parkinson's disease, and (iii) is most relevant for people of European, Ashkenazi Jewish, and North African Berber descent. The Hereditary Thrombophilia genetic health risk report (i) is indicated for reporting of the Factor V Leiden variant in the F5 gene, and the Prothrombin G20210A variant in the F2 gene, (ii) describes if a person has variants associated with a higher risk of developing harmful blood clots, and (iii) is most relevant for people of European descent. The Cystic Fibrosis carrier status report is indicated for the detection of 28 variants in the CFTR gene and is most relevant for people of Ashkenazi Jewish, European, and Hispanic/Latino descent. The Sickle Cell Anemia carrier status report is indicated for the detection of the HbS variant in the HBB gene and is most relevant for people of African descent. The carrier status reports related to hereditary hearing loss consist of two tests – one indicated for the detection of two variants in the GJB2 gene which is most relevant for people of Ashkenazi Jewish and European descent, and one indicated for the detection of six variants in the SLC26A4 gene.

**This data has undergone a general quality review however only a subset of markers have been individually validated for accuracy. The data from 23andMe's Browse Raw Data feature is suitable only for research, educational, and informational use and not for medical, diagnostic or other use.

23andMe kit 23andMe kit
Father's Day is June 18.

Father's Day is June 18. Save $20.

Save $20 / kit (limit 2)

Limit 2 kits. Offer ends June 18.

Choose your service

 

Ancestry

learn more

$99

Health + Ancestry

learn more

$199

Ancestry reports
DNA Relative Finder
Genetic Health Risk reports*
Carrier Status reports*
Wellness reports
Traits reports
See full list of reports
 

$99

order

$199

order
 

Health + Ancestry

learn more

$199

Ancestry

learn more

$99

Ancestry reports
DNA Relative Finder
Carrier Status reports*  
Wellness reports  
Traits reports  
See full list of reports
 

$199

order

$99

order

Order Health + Ancestry today for $199 and save $25. Add Health reports later for $125 (total cost $224).

No membership fee
No monthly subscription

*The 23andMe PGS test uses qualitative genotyping to detect clinically relevant variants in the genomic DNA of adults from saliva collected using an FDA-cleared collection device (Oragene·DX model OGD-500.001) for the purpose of reporting and interpreting genetic health risks and reporting carrier status. It is not intended to diagnose any disease. The relevance of each report varies based on ethnicity. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person's overall risk of developing the disease. These reports are not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication or how much of a medication you should take. Our carrier status reports can be used to determine carrier status, but cannot determine if you have two copies of any genetic variant. These carrier reports are not intended to tell you anything about your risk for developing a disease in the future or anything about the health of your fetus, or your newborn child's risk of developing a particular disease later in life. For Gaucher Disease Type 1, we provide a single report that includes information on both carrier status and genetic health risk. The Late-onset Alzheimer's Disease genetic health risk report is indicated for reporting of the ε4 variant in the APOE gene and describes if a person has a variant associated with an increased risk of developing late-onset Alzheimer's disease. The ε4 variant included in this report is found and has been studied in many ethnicities. Detailed risk estimates have been studied the most in people of European descent. The Alpha-1 Antitrypsin (AAT) Deficiency genetic health risk report (i) is indicated for reporting of the PI*Z and PI*S variants in the SERPINA1 gene, (ii) describes if a person has variants associated with AAT deficiency and a higher risk for lung and liver disease, and (iii) is most relevant for people of European descent. The Parkinson's Disease genetic health risk report (i) is indicated for reporting of the G2019S variant in the LRRK2 gene, and the N370S variant in the GBA gene, (ii) describes if a person has variants associated with an increased risk of developing Parkinson's disease, and (iii) is most relevant for people of European, Ashkenazi Jewish, and North African Berber descent. The Hereditary Thrombophilia genetic health risk report (i) is indicated for reporting of the Factor V Leiden variant in the F5 gene, and the Prothrombin G20210A variant in the F2 gene, (ii) describes if a person has variants associated with a higher risk of developing harmful blood clots, and (iii) is most relevant for people of European descent. The Cystic Fibrosis carrier status report is indicated for the detection of 28 variants in the CFTR gene and is most relevant for people of Ashkenazi Jewish, European, and Hispanic/Latino descent. The Sickle Cell Anemia carrier status report is indicated for the detection of the HbS variant in the HBB gene and is most relevant for people of African descent. The carrier status reports related to hereditary hearing loss consist of two tests – one indicated for the detection of two variants in the GJB2 gene which is most relevant for people of Ashkenazi Jewish and European descent, and one indicated for the detection of six variants in the SLC26A4 gene.